Hospital-acquired infectious endocarditis not associated with cardiac surgery: An emerging problem

Clinical Infectious Diseases

Volumn 20, Issue 1, 1995, Pages 16-23

  Fernández Guerrero, Manuel L ^a   Verdejo, Carlos ^a   Azofra, José ^a   De GÓrgolas, Miguel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; CLINICAL EXAMINATION; ENTEROCOCCUS FAECALIS; HEART SURGERY; HOSPITAL INFECTION; HUMAN; INFECTION SENSITIVITY; INFECTIOUS COMPLICATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VEIN CATHETERIZATION;

BACTEREMIA; BIOPSY; CARDIAC SURGICAL PROCEDURES; CATHETERIZATION; CROSS INFECTION; ENDOCARDITIS; ENDOCARDITIS, BACTERIAL; FEMALE; FUNGEMIA; HUMAN; MALE; MIDDLE AGE; PROGNOSIS; RETROSPECTIVE STUDIES; SPAIN; UROGENITAL DISEASES;

EID: 0028855138     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.1.16     Document Type: Article

References (58)

1. Maki DG. Nosocomial bacteremia: an epidemiologic overview. Am J Med 1981;70:719-32.
2. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States-1989-1990. Am J Med 1991;91 (suppl 3B):86S-9S.
3. Power J, Wing EJ, Talamo TS, Stanko R. Fatal bacterial endocarditis as a complication of permanent indwelling catheters: report of two cases. Am J Med 1986; 81:166-8.
4. Rowley KM, Clubb KS, Smith GJW, Cabin HS. Right-sided infective endocarditis as a consequence of flow-directed pulmonary-artery catheterization: a clinicopathological study of 55 autopsied patients. N Engl J Med 1984; 311:1152-6.
5. Guze LB, Pearce ML. Hospital-acquired bacterial endocarditis. Arch Intern Med 1963; 112:56-62.
6. Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983;98:447-55.
7. von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981;94:505-18.
8. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991;114:635-40.
9. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15:197-210.
10. Anderson ET, Young LS, Hewitt WL. Simultaneous antibiotic levels in “breakthrough” gram-negative rod bacteremia. Am J Med 1976;61:493-7.
11. Weinstein MP, Reller LB. Clinical importance of “breakthrough” bacteremia. Am J Med 1984;76:175-80.
12. Fernandez Guerrero ML, Barros C, Rodriguez Tudela JL, Fernandez Roblas R, Soriano F. Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis. Eur J Clin Microbiol Infect Dis 1988;7:525-7.
13. Friedland G, von Reyn CF, Levy B, Arbeit R, Dasse P, Crumpacker C. Nosocomial endocarditis. Infect Control 1984;5:284-8.
14. Terpenning MS, Buggy BP, Kauffman CA. Hospital-acquired infective endocarditis. Arch Intern Med 1988;148:1601-3.
15. Pelletier LL Jr, Petersdorf RG. Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-1972. Medicine (Baltimore) 1977;56:287-313.
16. Garvey GJ, Neu HC. Infective endocarditis-an evolving disease: a review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973. Medicine (Baltimore) 1978;57:105-27.
17. Venezio FR, Westenfelder GO, Cook FV, Emmerman J, Phair JP. Infective endocarditis in a community hospital. Arch Intern Med 1982;142:789-92.
18. Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine (Baltimore) 1993;72:90-102.
19. Kazanjian PH. Infective endocarditis: review of 60 cases treated in community hospitals. Infect Dis Clin Pract 1993;2:41-6.
20. Watanakunakorn C, Baird IM. Staphylococcus aureus bacteremia and endocarditis associated with a removable infected intravenous device. Am J Med 1977;63:253-6.
21. Ehni WF, Reller LB. Short-course therapy for catheter-associated Staphylococcus aureus bacteremia. Arch Intern Med 1989; 149:533-6.
22. Mirimanoff RO, Glauser MP. Endocarditis during Staphylococcus aureus septicemia in a population of non-drug-addicts. Arch Intern Med 1982;142:1311-3.
23. Greene JF, Fitzwater JE, Clemmer TP. Septic endocarditis and indwelling pulmonary artery catheters. JAMA 1975;233:891-2.
24. Tsao MMP, Katz D. Central venous catheter-induced endocarditis: human correlate of the animal experimental model of endocarditis. Rev Infect Dis 1984;6:783-90.
25. Gould K, Ramirez-Ronda CH, Holmes RK, Sanford JP. Adherence of bacteria to heart valves in vitro. J Clin Invest 1975;56:1364-70.
26. Fang G, Keys TF, Gentry LO, et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia: a prospective multicenter study. Ann Intern Med 1993; 119:560-7.
27. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988;67:248-69.
28. Whiteside M, Moore J, Ratzan K. An investigation of enterococcal bacteremia. Am J Infect Control 1983; 11:125-9.
29. Centers for Disease Control. Nosocomial infection surveillance, 1984. CDC surveillance summaries. MMWR Morb Mortal Wkly Rep 1986;35(suppl 1SS): 17SS-29SS.
30. Garrison RN. Fry DE, Berberich S, Polk HC Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg 1982;196:43-7.
31. Wells LD, von Graevenitz A. Clinical significance of enterococci in blood cultures from adult patients. Infection 1980;8:147-51.
32. Malone DA, Wagner RA, Myers JP, Watanakunakorn C. Enterococcal bacteremia in two large community teaching hospitals. Am J Med 1986;81:601-6.
33. Shlaes DM, Levy J, Wolinsky E. Enterococcal bacteremia without endocarditis. Arch Intern Med 1981;141:578-81.
34. Megran DW. Enterococcal endocarditis. Clin Infect Dis 1992; 15: 63-71.
35. Lerner PL Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med 1966;274:199-206, 259-66, 323-31, 388-93.
36. Herzstein J, Ryan JL, Mangi RJ, Greco TP, Andriole VT. Optimal therapy for enterococcal endocarditis. Am J Med 1984:76:186-91.
37. Mandell GL, Kaye D, Levison ME, Hook EW. Enterococcal endocarditis: an analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med 1970; 125:258-64.
38. Wilson WR. Wilkowske CJ, Wright AJ, Sande MA, Geraci JE. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med 1984; 100:816-23.
39. Moellering RC, Watson BK, Kunz LJ. Endocarditis due to group D streptococci: comparison of disease caused by Streptococcus horis with that produced by the enterococci. Am J Med 1974;57:239-50.
40. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS. Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med 1987;106:687-91.
41. Bayer AS. Staphylococcal bacteremia and endocarditis: state of the art. Arch Intern Med 1982; 142:1169-77.
42. Rahal JJ, Chan Y-K, Johnson G. Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staph ylococcus aureus bacteremia. Am J Med 1986:81:43-52.
43. Iannini PB, Crossley K. Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann Intern Med 1976;84:558-60.
44. Mylotte JM, McDermott C, Spooner J A. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987;9:891-907.
45. Libman H. Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984; 144:541-5.
46. Raad I, Narro J, Khan A, Tarrand J. Vartivarian S. Bodey GP. Serious complications of vascular catheter-related Staph ylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 1992;11:675-82.
47. Fernandez-Guerrero ML. Aguado JM, Gomez Garces JL. Staphylococcus aureus bacteremia associated with intravenous catheters. Is it a mild disease? [abstract no 483], In: Proceedings of the IXth International Congress of Infectious and Parasitic Diseases. Munich: Futur-amed Verlag, 1986.
48. Watanakunakorn C. Staphylococcus aureus endocarditis. 1980-1991: an analysis of 106 cases [abstract no 1144], In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington. DC: American Society for Microbiology, 1993.
49. Chambers HF. Short-course combination and oral therapies of Staph ylococcus aureus endocarditis. Infect Dis Clin North Am 1993;7:69-80.
50. Freedman LR. Valone J. Experimental infective endocarditis. Prog Cardiovasc Dis 1979:22:169-80.
51. Eng RHK., Bishburg E, Smith SM, Scadutto P. Staphylococcus aureus bacteremia during therapy. J Infect Dis 1987;155:1331-5.
52. Raad LL, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 1992; 14:75-82.
53. Jernigan JA, Farr BM. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med 1993;119:304-11.
54. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990;89:137-41.
55. Rahal JJ. Preventing second-generation complications due to Staph ylococcus aureus [editorial]. Arch Intern Med 1989; 149:503-4.
56. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of rightsided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989;2:1071-3.
57. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988; 109:619-24.
58. Dajani AS., Bisno AL, Chung KJ. et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1990;264:2919-22.